表紙:エラストマー輸液ポンプの世界市場:業界動向、シェア、規模、成長、機会、予測(2021年~2026年)
市場調査レポート
商品コード
1046059

エラストマー輸液ポンプの世界市場:業界動向、シェア、規模、成長、機会、予測(2021年~2026年)

Elastomer Infusion Pump Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

出版日: | 発行: IMARC Services Private Limited | ページ情報: 英文 143 Pages | 納期: 2~3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=135.61円
エラストマー輸液ポンプの世界市場:業界動向、シェア、規模、成長、機会、予測(2021年~2026年)
出版日: 2021年12月10日
発行: IMARC Services Private Limited
ページ情報: 英文 143 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 目次
概要

世界のエラストマー輸液ポンプの市場規模は、2015年から2020年にかけて緩やかな成長を示しました。2021年から2026年にかけて市場は約7%のCAGRで成長すると予想されています。

座りっぱなしの生活、大気汚染の深刻化、アルコールやタバコを吸う人の増加などにより、がんの罹患率が上昇しており、化学療法の必要性が高まっています。このことが市場成長の主な要因の一つとなっています。また、高齢者では細胞の修復機能が低下するため、加齢に伴いがん発症のリスクが大幅に上昇します。そのため、高齢者人口の増加も市場拡大の大きな要因となっています。さらに、病院の負担が増加していることに加え、在宅医療への移行が進んでいることから、従来の電動ポンプよりもエラストマー製輸液ポンプの市場が世界的に拡大しています。

当レポートでは、世界のエラストマー輸液ポンプ市場について調査しており、市場分析、価格分析、競合情勢など、包括的な情報を提供しています。

目次

第1章 序文

第2章 範囲と調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

第5章 世界のエラストマー輸液ポンプ市場

  • 市場概要
  • 市場パフォーマンス
  • COVID-19の影響

第6章 市場セグメンテーション:製品別

  • 連続速度ポンプ
  • 可変速度ポンプ

第7章 市場セグメンテーション:アプリケーション別

  • 疼痛管理
  • 感染管理
  • 化学療法
  • その他

第8章 市場セグメンテーション:エンドユーザー別

  • 病院とクリニック
  • 外来治療
  • その他

第9章 市場セグメンテーション:地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東とアフリカ
    • 市場セグメンテーション:国別

第10章 SWOT分析

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

第13章 価格分析

第14章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業プロファイル
    • Avanos Medical Inc.
    • B. Braun Melsungen AG
    • Baxter International Inc.
    • Daiken Medical Co. Ltd.
    • Nipro Corporation
    • O&M Halyard Inc
    • Palex Medical S.A.
    • Pfizer Inc.(Hospira Inc.)
    • pfm medical ag.
    • Samtronic Industria e Comercio LTDA
    • Smiths Group plc.
    • Woo Young Medical Co. Ltd
目次
Product Code: SR1020H118_Report

The global elastomer infusion pump market exhibited moderate growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of around 7% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

Elastomer infusion pumps are medical devices used to administer liquid drugs, such as chemotherapy, antibiotics, fluorouracil (5FU), analgesics, and anesthetics, intravenously depending on the therapy required. They contain balloon-like chambers that exert pressure to deliver drugs safely at a steady rate. Nowadays, elastomer infusion pumps that are disposable, compact, portable, and lightweight are widely available for residential purposes. Moreover, several manufacturers are offering products with high flow rate accuracy, minimal residual volume for complete drug administration, and an inline filter to reduce the risk of air embolism and particle contamination.

Elastomer Infusion Pump Market Trends:

  • A rise in the prevalence of cancer on account of sedentary lifestyles, growing air pollution, and the increasing number of individuals who consume alcohol and smoke tobacco is resulting in the significant need for chemotherapy. This represents one of the primary factors impelling the market growth. In addition, as cellular repair is less effective in older individuals, the risk of developing cancer rises considerably with age. Consequently, the increasing geriatric population is acting as another significant growth-inducing factor. Apart from this, due to the growing cases of coronavirus disease (COVID-19), healthcare facilities across the globe are relying on elastomeric infusion pumps to ensure adequate treatment of critically ill patients. The use of disposable, single-infusion elastomeric pumps also reduces the risk of cross-contamination between patients and healthcare professionals. Moreover, the escalating number of orthopedic procedures and surgeries is influencing the need for elastomer infusion pumps for post-operative pain management. Furthermore, the increasing burden on hospitals, in confluence with shifting preferences towards home-based care, is stimulating the market for elastomer infusion pumps over conventional electric pumps worldwide.

Key Market Segmentation:

  • IMARC Group provides an analysis of the key trends in each sub-segment of the global elastomer infusion pump market, along with forecasts at the global, regional and country level from 2021-2026. Our report has categorized the market based on product, application and end user.

Breakup by Product:

  • Continuous Rate Pumps
  • Variable Rate Pumps

Breakup by Application:

  • Pain Management
  • Infection Management
  • Chemotherapy
  • Others

Breakup by End User:

  • Hospitals and Clinics
  • Ambulatory Care
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Avanos Medical Inc., B. Braun Melsungen AG, Baxter International Inc., Daiken Medical Co. Ltd., Nipro Corporation, O&M Halyard Inc, Palex Medical S.A., Pfizer Inc. (Hospira Inc.), pfm medical ag., Samtronic Industria e Comercio LTDA, Smiths Group plc. and Woo Young Medical Co. Ltd. Key Questions Answered in This Report:

  • How has the global elastomer infusion pump market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global elastomer infusion pump market?
  • What are the key regional markets?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global elastomer infusion pump market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Elastomer Infusion Pump Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Continuous Rate Pumps
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Variable Rate Pumps
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Pain Management
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Infection Management
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Chemotherapy
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals and Clinics
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Ambulatory Care
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Avanos Medical Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
    • 14.3.2 B. Braun Melsungen AG
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 SWOT Analysis
    • 14.3.3 Baxter International Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Daiken Medical Co. Ltd.
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
    • 14.3.5 Nipro Corporation
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 O&M Halyard Inc
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 Palex Medical S.A.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 Pfizer Inc. (Hospira Inc.)
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 pfm medical ag.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 Samtronic Industria e Comercio LTDA
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
    • 14.3.11 Smiths Group plc.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis
    • 14.3.12 Woo Young Medical Co. Ltd
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio